1-(3-((4-amino-3-(6-ethoxynaphthalen-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)azetidin-1-yl)ethanone

ID: ALA4582694

PubChem CID: 155558144

Max Phase: Preclinical

Molecular Formula: C23H24N6O2

Molecular Weight: 416.49

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCOc1ccc2cc(-c3nn(CC4CN(C(C)=O)C4)c4ncnc(N)c34)ccc2c1

Standard InChI:  InChI=1S/C23H24N6O2/c1-3-31-19-7-6-16-8-18(5-4-17(16)9-19)21-20-22(24)25-13-26-23(20)29(27-21)12-15-10-28(11-15)14(2)30/h4-9,13,15H,3,10-12H2,1-2H3,(H2,24,25,26)

Standard InChI Key:  YEVFGVGSJHZJGK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    9.7558   -9.6586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7441  -10.4757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4452  -10.8938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4377  -11.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2099  -11.9723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4495  -12.7502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2369  -12.9744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9496  -12.5754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3486  -13.2882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1360  -13.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7213  -12.9371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3379  -14.2997    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6359  -13.6872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6987  -11.3143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2272  -10.6501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4886   -9.8737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9485   -9.2608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2099   -8.4886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0114   -8.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2770   -7.5528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0785   -7.3934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3400   -6.6211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1415   -6.4617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3617   -5.6744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6146   -8.0103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3532   -8.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5516   -8.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2902   -9.7143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7208  -12.1099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0197  -11.6918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0313  -10.8747    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
  9 13  1  0
  7 13  1  0
  5 14  1  0
 14 15  2  0
  3 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 21 25  1  0
 25 26  2  0
 19 27  1  0
 26 27  1  0
 27 28  2  0
 16 28  1  0
  4 29  2  0
 29 30  1  0
 30 31  2  0
  2 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4582694

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 416.49

Molecular Weight (Monoisotopic): 416.1961

AlogP: 3.11

#Rotatable Bonds: 5

Polar Surface Area: 99.16

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 4.08

CX LogP: 1.98

CX LogD: 1.98

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.54

Np Likeness Score: -0.98

References

1. Vidadala RS, Rivas KL, Ojo KK, Hulverson MA, Zambriski JA, Bruzual I, Schultz TL, Huang W, Zhang Z, Scheele S, DeRocher AE, Choi R, Barrett LK, Siddaramaiah LK, Hol WG, Fan E, Merritt EA, Parsons M, Freiberg G, Marsh K, Kempf DJ, Carruthers VB, Isoherranen N, Doggett JS, Van Voorhis WC, Maly DJ..  (2016)  Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.,  59  (13): [PMID:27309760] [10.1021/acs.jmedchem.6b00760]

Source

Source(1):

• Scientific Literature